Not Signed In - Pharmaxis Receives UK Approval For Phase III Cystic Fibrosis Trial
Sat, 07 Oct 2006 07:00 AM EST
... Specialist pharmaceutical company Pharmaxis Ltd (ASX: PXS; Nasdaq: PXSL) has received approval from the U.K. Medicines Healthcare products Regulatory Agency (MHRA) to begin the UK arm of an international Phase III clinical trial to evaluate Bronchitol in patients suffering from cystic fibrosis. [click link for full article] ...
Related Topics
- Cystic Fibrosis
- Clinical Trials
- Pulmonary Fibrosis
- Cystic Hygroma
- Antithrombin III
- Tarceva
- CMP
- Familial Dysautonomia
- Vaccine Testing & Approval
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Mastitis
- Congenital antithrombin III deficiency
- Cystic changes in the brain
- Cranial mononeuropathy III - diabetic type
- Cranial mononeuropathy III - compression type
- Fibrosis
- Antithrombin
- Medullary cystic kidney disease
- Hepatic Fibrosis
email this page
print this page
bookmark this page
feedback on this page
